Gavreto (Pralsetinib)
100 mg/1 · Capsule
By Rigel Pharmaceuticals, Inc.
- NDC
- 71332-006
- Route
- Oral
- Therapeutic class
- Kinase Inhibitor , Rearranged during Transfection (RET) Inhibitors [MoA]
- Marketing category
- NDA
Package sizes
- 60 CAPSULE in 1 BOTTLE (71332-006-60)NDC 71332-006-60Available to order
- 90 CAPSULE in 1 BOTTLE (71332-006-90)NDC 71332-006-90Available to order
- 120 CAPSULE in 1 BOTTLE (71332-006-12)NDC 71332-006-12Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.
Related in Ophthalmic & Otic
See all →6% HETASTARCH IN 0.9% SODIUM CHLORIDE
6 g/100mL · Injection Solution
HF Acquisition Co LLC, DBA HealthFirst
Available to source
FNG
Liquid
Deseret Biologicals, Inc.
Available to source

Bact Combination
Liquid
Deseret Biologicals, Inc.
Available to source

Bact Combination
Liquid
Deseret Biologicals, Inc.
Available to source
